Spero Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. 

CEO
Esther Rajavelu
CEOEsther Rajavelu
Employees
32
Employees32
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
32
Employees32

SPRO Key Statistics

Market cap
36.77M
Market cap36.77M
Price-Earnings ratio
-0.51
Price-Earnings ratio-0.51
Dividend yield
—
Dividend yield—
Average volume
123.43K
Average volume123.43K
High today
$0.6808
High today$0.6808
Low today
$0.6338
Low today$0.6338
Open price
$0.6689
Open price$0.6689
Volume
89.35K
Volume89.35K
52 Week high
$1.61
52 Week high$1.61
52 Week low
$0.5052
52 Week low$0.5052

People also own

Based on the portfolios of people who own SPRO. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
Plug Power
NIO
Editas Medicine
SNDL
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.